Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03454295 · ClinicalTrials.gov registry record · Early Phase 1
Easing Psychosocial Burden for Informal Caregivers
A Early Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 64
- Enrollment target
NCT03454295: Completed Early Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03454295 is a Early Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03454295, a Early Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
The overall goal of this study is to determine the best time to offer Meaning-Centered Psychotherapy (MCP), an intervention that has proven to be helpful in improving spiritual well-being and decreasing existential distress among patients with advanced cancer, to caregivers. (MCP has also been shown to be an appropriate method of attending to the palliative or comfort care needs of caregivers of patients with cancer. Studies show that the psychological burden associated with caring for a patient with advanced cancer is often greater than that experienced by the patients themselves.) The investigators would also like to find out about caregivers initial impressions of MCP-C, Meaning-Centered Psychotherapy for Cancer Caregivers, so that the intervention can be adjusted to meet the unique needs of caregivers of patients with Glioblastoma.
Interventions
- BEHAVIORAL Focus Group
- BEHAVIORAL Meaning-Centered Psychotherapy for Cancer Caregivers / MCP-C
- BEHAVIORAL Enhanced Usual Care / EUC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2024-03-26 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03454295
The ClinicalTrials.gov registry entry for NCT03454295 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Focus Group is the first listed.
NCT03454295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03454295 about?
NCT03454295 is a clinical study titled "Easing Psychosocial Burden for Informal Caregivers". The overall goal of this study is to determine the best time to offer Meaning-Centered Psychotherapy (MCP), an intervention that has proven to be helpful in improving spiritual well-being and decreasing existential distress among patients with advanced cancer, to caregivers. (MCP has also been shown...
What is the current status of trial NCT03454295?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 64 participants. The study started on 2018-02-12. Estimated completion is 2024-03-26.
What interventions are being tested in trial NCT03454295?
The interventions under investigation include: Focus Group (BEHAVIORAL), Meaning-Centered Psychotherapy for Cancer Caregivers / MCP-C (BEHAVIORAL), Enhanced Usual Care / EUC (BEHAVIORAL).
Who is sponsoring clinical trial NCT03454295?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.